Tenzing Acquisition Corp. and Reviva Pharmaceuticals, Inc. Announce Shareholder Meeting Date to Approve the Business Combination
NYC and CUPERTINO, Calif., (GLOBE NEWSWIRE) — Tenzing Acquisition Corp., a unique function purchase business included in the Uk Virgin Islands (вЂњTenzingвЂќ) (NASDAQ: TZAC), and Reviva Pharmaceuticals, Inc., a Delaware company (вЂњRevivaвЂќ) and a California-based clinical-stage pharmaceutical business developing treatments that address unmet medical requirements into the aspects of nervous system (CNS), cardiovascular, metabolic, and inflammatory conditions, today announced that an exceptional General Meeting of investors of Tenzing (the “Shareholder fulfilling”) to accept the pending company combination between Tenzing and Reviva (the вЂњBusiness CombinationвЂќ) is planned become held, Eastern time. Due to COVID-19 limitations on in-person conferences, the Shareholder Meeting will likely to be entirely digital and performed via live webcast.
Tenzing filed its definitive proxy statement/prospectus with regards to the Shareholder fulfilling related to your Business mix (the “Proxy declaration”) using the U.S. Securities and Exchange Commission (the “SEC”) and started mailing it to Tenzing investors. The Proxy Statement is present regarding the SEC internet site. Holders of Tenzing’s ordinary stocks in the close of company regarding the record date have entitlement to notice associated with digital Shareholder Meeting and also to vote during the digital Shareholder Meeting. Continue reading Tenzing Acquisition Corp. and Reviva Pharmaceuticals, Inc. Announce Shareholder Meeting Date to Approve the Business Combination